ARRIVE - ABATACEPT RESEARCHED IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE ANTI-TNF RESPONSE TO VALIDATE EFFECTIVENESS
USPTO (United States) · Serial 77700548
- Status
- abandoned
- Status updated
- 8 January 2014
- Filing date
- 27 March 2009
- Registration date
- -
- Nice classification
- 42
- Owner
- Bristol-Myers Squibb Company
- Owner country
- US
- Raw status code
- 602
As filed by US
Authoritative source
The official US trademark record is at USPTO TSDR (serial 77700548) ↗. Where our data differs from the USPTO record, theirs is correct.
See methodology for refresh cadence + status normalisation. See sources for licensing.